|
|
|
Insider
Information: |
Bvf Inc/il |
Relationship: |
Indirect Beneficial Ow... |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
12 |
|
Direct
Shares |
49,829,941 |
|
Indirect Shares
|
136,880,248 |
|
|
Direct
Value |
$2,490,637,717 |
|
|
Indirect Value
|
$7,464,070,827 |
|
|
Total
Shares |
186,710,189 |
|
|
Total
Value |
$9,954,708,545 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
19
|
2
|
Stock
price went up :
|
18
|
0
|
Stock
price went down : |
1
|
2
|
|
|
|
Gain/Loss Ratio : |
18.0
|
-2.0
|
Percentage
Gain/Loss : |
64.8%
|
-200.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Neurocrine Biosciences Inc |
NBIX |
10% Owner |
2010-04-12 |
5,041,447 |
2010-04-12 |
15,124,341 |
Premium* |
|
NPS Pharmaceuticals Inc |
NPSP |
Indirect Beneficial Ow... |
2008-03-11 |
0 |
2008-09-22 |
4,383,115 |
Premium* |
|
Astex Pharmaceuticals Inc |
ASTX |
Indirect Beneficial Ow... |
2008-05-01 |
0 |
2008-05-09 |
5,753,399 |
Premium* |
|
Neurobiological Technologies Inc |
NTII |
10% Owner |
2009-10-21 |
331,998 |
2009-10-21 |
995,994 |
Premium* |
|
Epirus Biopharmaceuticals Inc |
EPRS |
10% Owner |
2009-12-22 |
6,830,972 |
2009-12-22 |
20,492,916 |
Premium* |
|
Capstone Therapeutics Corp |
CAPS |
Indirect Beneficial Ow... |
2008-10-10 |
0 |
2008-10-14 |
5,136,888 |
Premium* |
|
Adolor Corp |
ADLR |
Indirect Beneficial Ow... |
2008-10-10 |
4,428,032 |
2008-10-31 |
6,214,551 |
Premium* |
|
Dynavax Technologies Corp |
DVAX |
10% Owner |
2009-09-10 |
4,278,851 |
2009-09-10 |
12,836,553 |
Premium* |
|
Ligand Pharmaceuticals Inc |
LGND |
Indirect Beneficial Ow... |
2009-07-01 |
15,169,950 |
2009-07-01 |
45,509,850 |
Premium* |
|
Curis Inc |
CRIS |
Indirect Beneficial Ow... |
2009-02-03 |
8,921,716 |
2009-04-27 |
5,951,716 |
Premium* |
|
Repligen Corp |
RGEN |
Indirect Beneficial Ow... |
2009-07-07 |
2,765,050 |
2009-07-07 |
8,295,150 |
Premium* |
|
Gyre Therapeutics |
GYRE |
Indirect Beneficial Ow... |
2009-10-16 |
2,061,925 |
2009-10-16 |
6,185,775 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
195 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 8
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2009-07-01 |
4 |
S |
$2.97 |
$423,633 |
D/D |
(142,700) |
15,169,950 |
0 |
- |
|
ADLR |
Adolor Corp |
Indirect Beneficial Owner |
|
2008-10-23 |
4 |
B |
$3.22 |
$426,099 |
I/I |
132,300 |
4,710,132 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-03-06 |
4 |
B |
$5.00 |
$433,162 |
I/I |
86,700 |
4,168,400 |
1.5 |
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-15 |
4 |
B |
$0.65 |
$462,800 |
I/I |
712,000 |
5,796,799 |
1.5 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-03-10 |
4 |
B |
$3.73 |
$469,350 |
I/I |
126,000 |
4,608,215 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-28 |
4 |
B |
$1.99 |
$479,612 |
I/I |
240,600 |
13,060,253 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-03-03 |
4 |
B |
$4.93 |
$483,013 |
I/I |
98,000 |
4,058,500 |
1.5 |
- |
|
DVAX |
Dynavax Technologies Corp |
Direct Beneficial Owner |
|
2009-07-27 |
4 |
S |
$1.99 |
$488,215 |
D/D |
(245,100) |
6,068,557 |
0 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-07-07 |
4 |
B |
$4.24 |
$490,718 |
I/I |
115,700 |
5,208,200 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-02-21 |
4 |
B |
$4.70 |
$498,582 |
I/I |
106,000 |
3,340,300 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-01-15 |
4 |
B |
$4.65 |
$498,655 |
I/I |
107,300 |
6,062,877 |
1.5 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-07-01 |
4 |
S |
$5.42 |
$514,900 |
I/I |
(95,000) |
1,395,351 |
|
- |
|
EPRS |
Epirus Biopharmaceuticals... |
Indirect Beneficial Owner |
|
2008-10-07 |
4 |
B |
$0.66 |
$518,003 |
I/I |
790,000 |
4,897,899 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-03-07 |
4 |
B |
$4.99 |
$521,912 |
I/I |
104,600 |
4,273,000 |
1.5 |
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-01-09 |
4 |
B |
$4.29 |
$525,966 |
I/I |
122,700 |
5,606,550 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-02-25 |
4 |
B |
$4.96 |
$535,205 |
I/I |
108,000 |
3,527,300 |
1.5 |
- |
|
NPSP |
NPS Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2008-03-07 |
4 |
B |
$3.81 |
$556,057 |
I/I |
146,100 |
4,482,215 |
1.5 |
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-01-20 |
4 |
S |
$6.00 |
$570,000 |
I/I |
(95,000) |
1,580,351 |
|
- |
|
ARNA |
Arena Pharmaceuticals Inc |
Indirect Beneficial Owner |
|
2004-01-14 |
4 |
S |
$6.05 |
$574,750 |
I/I |
(95,000) |
1,626,351 |
|
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-05-15 |
4 |
B |
$4.63 |
$584,453 |
I/I |
126,300 |
5,001,400 |
1.5 |
- |
|
CAPS |
Capstone Therapeutics Cor... |
Indirect Beneficial Owner |
|
2008-10-14 |
4 |
B |
$0.63 |
$598,083 |
I/I |
946,500 |
5,136,888 |
1.5 |
- |
|
LGND |
Ligand Pharmaceuticals In... |
Indirect Beneficial Owner |
|
2008-11-25 |
4 |
B |
$1.77 |
$625,481 |
I/I |
353,000 |
11,469,653 |
1.5 |
- |
|
AMAG |
AMAG Pharmaceuticals Inc |
officerTitle |
|
2005-01-13 |
4 |
S |
$15.40 |
$670,978 |
I/I |
(43,570) |
985,163 |
|
- |
|
ARQL |
Arqule Inc |
Indirect Beneficial Owner |
|
2008-01-23 |
4 |
B |
$4.47 |
$690,969 |
I/I |
154,600 |
6,217,477 |
1.5 |
- |
|
NBIX |
Neurocrine Biosciences In... |
Indirect Beneficial Owner |
|
2008-03-11 |
4 |
B |
$4.90 |
$694,267 |
I/I |
141,800 |
4,639,800 |
1.5 |
- |
|
195 Records found
|
|
Page 6 of 8 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|